Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
IQVIA Holdings ( (IQV) ) has shared an announcement.
On May 7, 2026, IQVIA Holdings Inc. announced that its board of directors approved an additional $2 billion for its common stock repurchase authorization, lifting the remaining capacity under its existing buyback program to approximately $3.2 billion. The program has no expiration date, and purchases may be carried out through open-market trades, block transactions or privately negotiated deals, with management retaining flexibility to adjust or discontinue repurchases based on market conditions and corporate needs.
The expanded repurchase authorization signals continued confidence by IQVIA’s leadership in the company’s long-term prospects and capital-generation capacity, potentially supporting earnings per share and shareholder returns over time. However, the discretionary structure of the program means actual buyback levels will depend on factors such as stock price, overall market environment and strategic capital allocation, leaving investors to watch execution closely for insight into management’s priorities.
The most recent analyst rating on (IQV) stock is a Buy with a $210.00 price target. To see the full list of analyst forecasts on IQVIA Holdings stock, see the IQV Stock Forecast page.
Spark’s Take on IQV Stock
According to Spark, TipRanks’ AI Analyst, IQV is a Neutral.
The score is led by strong earnings-call momentum (raised EPS guidance, record results, solid bookings/backlog) but is capped by financial risk from high leverage and recent margin/free-cash-flow pressure. Technicals also weigh on the score due to a pronounced downtrend, while valuation is moderate based on a mid-range P/E and no dividend yield provided.
To see Spark’s full report on IQV stock, click here.
More about IQVIA Holdings
IQVIA Holdings Inc. is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Powered by its Connected Intelligence platform, the company combines high-quality health data, AI-driven analytics, and technology to support biopharma, medtech, researchers and governments, operating with about 93,000 employees in over 100 countries.
Average Trading Volume: 2,078,582
Technical Sentiment Signal: Sell
Current Market Cap: $29.45B
For a thorough assessment of IQV stock, go to TipRanks’ Stock Analysis page.